SCHEMBL10040109

SCHEMBL10040109

O=[N+]([O-])c1cc(-c2cccnc2)ccc1S(=O)(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.61
KIF18A Q8NI77 1/20 0.56
KMT2A Q03164 3/20 0.54
CYP11B1 P15538 3/20 0.50
CYP11B2 P19099 3/20 0.50
MEN1 O00255 2/20 0.48
RAB9A P51151 1/20 0.48
THRB P10828 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
FLT3 P36888 1/20 0.42
ABCB1 P08183 1/20 0.42
ABCC1 P33527 1/20 0.42
NPY1R P25929 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15307422 0.87 KIF18A (0.68) HTR6KIF18AKMT2AMEN1RAB9A
SCHEMBL10040106 0.79 HTR6 (0.67) HTR6CYP11B1CYP11B2MEN1RXFP1
SCHEMBL1663904 0.78 CYP11B1 (0.57) CYP11B1CYP11B2MEN1RAB9ACA12
SCHEMBL10040087 0.76 HTR6 (1.00) HTR6CYP11B1CYP11B2RXFP1CA12
SCHEMBL10905079 0.76 KMT2A (0.66) HTR6KIF18AKMT2AMEN1RAB9A
SCHEMBL29914888 0.75 HTR6 (0.61) HTR6CYP11B1CYP11B2RXFP1CA12
SCHEMBL4704336 0.74 ERN1 (0.56) CYP11B1CYP11B2CA12CA1CA2
SCHEMBL1980117 0.74 CYP11B1 (0.51) CYP11B1CYP11B2MEN1RAB9ACA12
SCHEMBL29580441 0.74 TDP1 (0.67) KMT2ACYP11B1CYP11B2MEN1RAB9A
SCHEMBL77083 0.74 TDP1 (0.67) KMT2ACYP11B1CYP11B2MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3072882-A1 SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR THE PRODUCTION AND USE THEREOF Alla Chem, LLC. (US) 2016-09-28 EP disclosed
US-8829002-B2 Substituted methyl amines, serotonin 5-HT6 receptor antagonists, methods for production and use thereof IVACHTCHENKO ALEXANDRE VASILIEVICH (US) 2014-09-09 US disclosed
US-8829002-B2 Substituted methyl amines, serotonin 5-HT6 receptor antagonists, methods for production and use thereof IVACHTCHENKO ALEXANDRE VASILIEVICH (US) 2014-09-09 US disclosed
US-20130267536-A1 SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF ALLA CHEM, LLC (US) 2013-10-10 US disclosed
US-20130267536-A1 SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF ALLA CHEM, LLC (US) 2013-10-10 US disclosed
WO-2012087182-A2 SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR THE PRODUCTION AND USE THEREOF АЛЛА ХЕМ, ЛЛС (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267536-A1 SUBSTITUTED METHYL AMINES, SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS, METHODS FOR PRODUCTION AND USE THEREOF HTR6, HTR1F, HTR1A HTR6 1/4885KIF18A 3510/4885KMT2A 842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.